Assignee profile:

Dermavant Sciences GmbH

City:

Basel

Country:

Switzerland

Published Applications:

31

Last publication date:

2026-03-12

Patent Grants:

22

Last grant date:

2025-03-18

Top Inventors for applications by Dermavant Sciences GmbH

These are the the leading inventors for applications assigned to Dermavant Sciences GmbH:

Recent patent applications by Dermavant Sciences GmbH

Dermavant Sciences GmbH based in Basel, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2026-03-12
US20260069585A1
Human necessities

ISOQUINOLINE COMPOUNDS AND THEIR USE IN TREATING AhR MEDIATED DISEASES

#2 | 2026-03-12
US20260069553A1
Human necessities

TAPINAROF AND ANALOGS THEREOF FOR USE IN TREATING AhR MEDIATED DISEASES

#3 | 2025-09-11
US20250282730A1
Chemistry; metallurgy

ISOQUINOLINE COMPOUNDS AND THEIR USE IN TREATING AhR IMBALANCE

#4 | 2025-08-28
US20250270158A1
Chemistry; metallurgy

PROCESS FOR PREPARING TAPINAROF

#5 | 2024-09-26
US20240315985A1
Human necessities

REMITTIVE EFFECTS OF TAPINAROF IN THE TREATMENT OF PLAQUE PSORIASIS, ATOPIC DERMATITIS, OR RADIATION DERMATITIS

#6 | 2024-08-29
US20240285550A1
Human necessities

TOPICAL PHARMACEUTICAL COMPOSITIONS

#7 | 2024-06-27 ✅ Patent 12,252,471 granted on 2025-03-18
US20240208910A1
Chemistry; metallurgy

Isoquinoline compounds and their use in treating AhR imbalance

#8 | 2023-12-28 ✅ Patent 11,938,099 granted on 2024-03-26
US20230414534A1
Human necessities

Use of tapinarof for the treatment of atopic dermatitis

#9 | 2023-07-20
US20230225987A1
Human necessities

TOPICAL PHARMACEUTICAL COMPOSITIONS

#10 | 2023-06-22 ✅ Patent 12,569,453 granted on 2026-03-10
US20230190673A1
Human necessities

USE OF TAPINAROF FOR THE TREATMENT OF ATOPIC DERMATITIS

#11 | 2023-06-08 ✅ Patent 12,275,696 granted on 2025-04-15
US20230174445A1
Chemistry; metallurgy

Process for preparing tapinarof

#12 | 2023-04-27
US20230126208A1
Human necessities

TOPICAL PHARMACEUTICAL COMPOSITIONS

#13 | 2023-04-20 ✅ Patent 11,827,605 granted on 2023-11-28
US20230124135A1
Chemistry; metallurgy

Isoquinoline compounds and their use in treating AhR imbalance

#14 | 2023-04-06
US20230106782A1
Human necessities

USE OF TAPINAROF FOR THE TREATMENT OF CHRONIC PLAQUE PSORIASIS

#15 | 2022-11-17 ✅ Patent 11,590,088 granted on 2023-02-28
US20220362171A1
Human necessities

Use of Tapinarof for the treatment of chronic plaque psoriasis

#16 | 2022-09-15 ✅ Patent 11,497,718 granted on 2022-11-15
US20220287989A9
Human necessities

Use of tapinarof for the treatment of atopic dermatitis

#17 | 2022-05-19 ✅ Patent 11,548,853 granted on 2023-01-10
US20220153703A1
Chemistry; metallurgy

Isoquinoline compounds and their use in treating AhR imbalance

#18 | 2022-01-20 ✅ Patent 11,267,788 granted on 2022-03-08
US20220017468A1
Chemistry; metallurgy

Isoquinoline compounds and their use in treating AhR imbalance

#19 | 2021-06-03 ✅ Patent 11,597,692 granted on 2023-03-07
US20210163388A1
Chemistry; metallurgy

Process for preparing tapinarof

#20 | 2021-01-28 ✅ Patent 10,961,175 granted on 2021-03-30
US20210024442A1
Chemistry; metallurgy

Process for preparing tapinarof

#21 | 2020-05-14 ✅ Patent 11,497,718 granted on 2022-11-15
US20200147001A1
Human necessities

Use of tapinarof for the treatment of atopic dermatitis

#22 | 2020-04-02 ✅ Patent 11,612,573 granted on 2023-03-28
US20200101027A1
Human necessities

Topical pharmaceutical compositions

#23 | 2019-06-27 ✅ Patent 11,622,945 granted on 2023-04-11
US20190192446A1
Human necessities

Topical pharmaceutical compositions

#24 | 2019-06-27 ✅ Patent 11,458,108 granted on 2022-10-04
US20190192445A1
Human necessities

Topical pharmaceutical compositions

#25 | 2019-05-23 ✅ Patent 10,426,743 granted on 2019-10-01
US20190151255A1
Human necessities

Topical pharmaceutical compositions

#26 | 2019-05-16 ✅ Patent 10,647,649 granted on 2020-05-12
US20190144367A1
Chemistry; metallurgy

Process for preparing tapinarof

#27 | 2019-05-09 ✅ Patent 10,357,495 granted on 2019-07-23
US20190134036A1
Human necessities

Topical formulations of PDE-4 inhibitors and their methods of use

#28 | 2018-03-08 ✅ Patent 11,617,724 granted on 2023-04-04
US20180064656A1
Human necessities

Topical pharmaceutical compositions

#29 | 2017-12-21 ✅ Patent 10,376,475 granted on 2019-08-13
US20170360719A1
Human necessities

Method of use

#30 | 2017-12-07 ✅ Patent 10,206,925 granted on 2019-02-19
US20170348311A1
Human necessities

Topical formulations of PDE-4 inhibitors and their methods of use

#31 | 2016-11-24 ✅ Patent 10,195,160 granted on 2019-02-05
US20160338973A1
Human necessities

Topical pharmaceutical compositions

Also check out Dermavant Sciences GmbH's (Basel, Switzerland) applicant profile with 28 patent applications submitted.

AssigneeID:

156613 ⎘